Raffa Wealth Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-32
| Closed | -$1.08K | – | 1594 |
|
|
2026
Q1 | $1.08K | Hold |
32
| – | – | ﹤0.01% | 926 |
|
|
2025
Q4 | $871 | Hold |
32
| – | – | ﹤0.01% | 953 |
|
|
2025
Q3 | $1.28K | Hold |
32
| – | – | ﹤0.01% | 833 |
|
|
2025
Q2 | $1.06K | Hold |
32
| – | – | ﹤0.01% | 854 |
|
|
2025
Q1 | $938 | Hold |
32
| – | – | ﹤0.01% | 848 |
|
|
2024
Q4 | $1.05K | Hold |
32
| – | – | ﹤0.01% | 862 |
|
|
2024
Q3 | $1.42K | Hold |
32
| – | – | ﹤0.01% | 728 |
|
|
2024
Q2 | $1.38K | Hold |
32
| – | – | ﹤0.01% | 808 |
|
|
2024
Q1 | $936 | Hold |
32
| – | – | ﹤0.01% | 908 |
|
|
2023
Q4 | $713 | Hold |
32
| – | – | ﹤0.01% | 908 |
|
|
2023
Q3 | $792 | Hold |
32
| – | – | ﹤0.01% | 847 |
|
|
2023
Q2 | $906 | Hold |
32
| – | – | ﹤0.01% | 824 |
|
|
2023
Q1 | $735 | Hold |
32
| – | – | ﹤0.01% | 880 |
|
|
2022
Q4 | $899 | Hold |
32
| – | – | ﹤0.01% | 810 |
|
|
2022
Q3 | $905 | Hold |
32
| – | – | ﹤0.01% | 834 |
|
|
2022
Q2 | $709 | Hold |
32
| – | – | ﹤0.01% | 926 |
|
|
2022
Q1 | $932 | Hold |
32
| – | – | ﹤0.01% | 892 |
|
|
2021
Q4 | $1.05K | Hold |
32
| – | – | ﹤0.01% | 846 |
|
|
2021
Q3 | $1.48K | Hold |
32
| – | – | ﹤0.01% | 696 |
|
|
2021
Q2 | $1.76K | Hold |
32
| – | – | ﹤0.01% | 659 |
|
|
2021
Q1 | $1.65K | Hold |
32
| – | – | ﹤0.01% | 690 |
|
|
2020
Q4 | $1.39K | Hold |
32
| – | – | ﹤0.01% | 654 |
|
|
2020
Q3 | $1.12K | Hold |
32
| – | – | ﹤0.01% | 638 |
|
|
2020
Q2 | $1.71K | Hold |
32
| – | – | ﹤0.01% | 511 |
|
|
2020
Q1 | $1.14K | Hold |
32
| – | – | ﹤0.01% | 552 |
|
|
2019
Q4 | $1.53K | Buy |
+32
| New | +$1.21K | ﹤0.01% | 465 |
|
|
2016
Q3 | – | Sell |
-5
| Closed | -$209 | – | 871 |
|
|
2016
Q2 | $209 | Hold |
5
| – | – | ﹤0.01% | 849 |
|
|
2016
Q1 | $203 | Hold |
5
| – | – | ﹤0.01% | 828 |
|
|
2015
Q4 | $325 | Hold |
5
| – | – | ﹤0.01% | 792 |
|
|
2015
Q3 | $353 | Hold |
5
| – | – | ﹤0.01% | 777 |
|
|
2015
Q2 | $556 | Hold |
5
| – | – | ﹤0.01% | 653 |
|
|
2015
Q1 | $472 | Buy |
+5
| New | +$560 | ﹤0.01% | 737 |
|
Other funds holding AGIO
FCM
LCM
AC
EAM
NAMI
Raffa Wealth Management's AGIO Position: Q2 2026 in Review
Raffa Wealth Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2026, closing a stake of 32 shares — an estimated $1.08K sold.
Raffa Wealth Management first reported a position in AGIO in Q1 2015 and held it in 32 quarters. The position peaked at $1.76K in Q2 2021. 217 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.
- Raffa Wealth Management reported no remaining Agios Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Raffa Wealth Management sold 32 Agios Pharmaceuticals shares in Q2 2026, an estimated $1.08K.
- Raffa Wealth Management first reported a position in Agios Pharmaceuticals in Q1 2015 and held it in 32 quarters.
- Raffa Wealth Management's Agios Pharmaceuticals position peaked at $1.76K in Q2 2021.
- 217 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.
Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.